Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01974258 |
| Title | Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Hoffmann-La Roche |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Los Angeles | California | 90025 | United States | Details | ||
| Sarasota | Florida | 34232 | United States | Details | ||
| Detroit | Michigan | 48201 | United States | Details | ||
| Canton | Ohio | 44718 | United States | Details | ||
| Oklahoma City | Oklahoma | 73104 | United States | Details | ||
| Nashville | Tennessee | 37203 | United States | Details |